Sideras P, Müller S, Shiels H, Jin H, Khan W N, Nilsson L, Parkinson E, Thomas J D, Brandén L, Larsson I
Unit of Applied Cell and Molecular Biology, Umeå University, Sweden.
J Immunol. 1994 Dec 15;153(12):5607-17.
Btk is a cytoplasmic protein tyrosine kinase (PTK) that has been directly implicated in the pathogenesis of X-linked agammaglobulinaemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. We have isolated phage and cosmid clones that allowed us to deduce the genomic structure of mouse and human Btk loci. The mouse and human genes are contained within genomic regions that span approximately 43.5 kb and 37.5 kb, respectively. Both loci contain 18 coding exons ranging between 55 and 560 bp in size with introns ranging in size from 164 bp to approximately 9 kb. The 5'-untranslated regions are encoded by single exons located approximately 9 kb upstream of the first coding exon. Exon 18 encodes for the last 23 carboxyl-terminal amino acids and the entire 3'-untranslated region. The location of intron/exon boundaries in the catalytic domains of the mouse and human Btk loci differs from that found in other described sub-families of intracellular PTKs, namely that of Src, Fes/Fer, Csk, and Abl/Arg. This observation is consistent with the classification of Btk together with the recently characterized kinases, Tec and Itk, into a separate sub-family of cytoplasmic PTKs. Putative transcription initiation sites in the mouse and human Btk loci have been determined by using the rapid amplification of cDNA ends assay. Similar to many other PTK specific genes, the putative Btk promoters lack obvious TATAA and CAAAT motifs. Putative initiator elements and potential binding sites for Ets (PEA-3), zeste, and PuF transcription factors are located within the 300 bp which are located upstream of the major transcription start site in both species. These sequences can mediate promoter activity when placed upstream of a promotorless chloramphenicol acetyl transferase reporter gene in an orientation-dependent manner. The present analysis will significantly facilitate the mutational analyses of patients with XLA and the further characterization of the function and regulation of the Btk molecule.
布鲁顿酪氨酸激酶(Btk)是一种细胞质蛋白酪氨酸激酶(PTK),它与人类X连锁无丙种球蛋白血症(XLA)和小鼠X连锁免疫缺陷(Xid)的发病机制直接相关。我们分离出了噬菌体和黏粒克隆,这些克隆使我们能够推断小鼠和人类Btk基因座的基因组结构。小鼠和人类基因分别位于跨度约为43.5 kb和37.5 kb的基因组区域内。两个基因座都包含18个编码外显子,大小在55至560 bp之间,内含子大小从164 bp到约9 kb不等。5'非翻译区由位于第一个编码外显子上游约9 kb处的单个外显子编码。外显子18编码最后23个羧基末端氨基酸和整个3'非翻译区。小鼠和人类Btk基因座催化结构域中内含子/外显子边界的位置与其他已描述的细胞内PTK亚家族(即Src、Fes/Fer、Csk和Abl/Arg)不同。这一观察结果与将Btk与最近鉴定的激酶Tec和Itk归为细胞质PTK的一个单独亚家族的分类一致。通过使用cDNA末端快速扩增分析确定了小鼠和人类Btk基因座中的推定转录起始位点。与许多其他PTK特异性基因相似,推定的Btk启动子缺乏明显的TATAA和CAAAT基序。推定的起始元件以及Ets(PEA-3)、zeste和PuF转录因子的潜在结合位点位于两个物种主要转录起始位点上游的300 bp内。当以方向依赖的方式置于无启动子的氯霉素乙酰转移酶报告基因上游时,这些序列可介导启动子活性。本分析将显著促进XLA患者的突变分析以及Btk分子功能和调控的进一步表征。